Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy

B Ozbakkaloglu; O Tünger; S Sürücüoglu; M Lekili; A R Kandiloglu

doi:10.1023/a:1007119706336

Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy

Int Urol Nephrol. 1999;31(1):49-53. doi: 10.1023/a:1007119706336.

Authors

B Ozbakkaloglu¹, O Tünger, S Sürücüoglu, M Lekili, A R Kandiloglu

Affiliation

¹ Department of Infectious Disease, Celal Bayar University, School of Medicine, Manisa, Turkey.

PMID: 10408303
DOI: 10.1023/a:1007119706336

Abstract

Although intravesical bacillus Calmette-Guerin (BCG) administration is an effective method in the treatment of superficial urinary bladder carcinoma, some complications may arise such as a granulomatous reaction either in the urinary tract or, in rare cases, outside the urinary tract. We report in this paper a case of granulomatous hepatitis following intravesical BCG administration.

Publication types

Case Reports

MeSH terms

Adjuvants, Immunologic / administration & dosage
Adjuvants, Immunologic / adverse effects*
Adjuvants, Immunologic / therapeutic use
Administration, Intravesical
BCG Vaccine / administration & dosage
BCG Vaccine / adverse effects*
BCG Vaccine / therapeutic use
Carcinoma, Transitional Cell / drug therapy
Granuloma / etiology*
Granuloma / pathology
Hepatitis / etiology*
Hepatitis / pathology
Humans
Liver / pathology
Male
Middle Aged
Urinary Bladder Neoplasms / drug therapy

Substances

Adjuvants, Immunologic
BCG Vaccine